Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer (original) (raw)
2017, Scientific Reports
visibility
…
description
8 pages
link
1 file
Related papers
The Journal of Pathology: Clinical Research, 2021
Identification of susceptibility loci in a mouse model of KRASG12D-driven pancreatic cancer
2010
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins
Gut, 2006
Genomic analysis of pancreatic cancer: a glimmer of hope for the therapy?
Translational Cancer Research, 2016
Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer
Cancer Discovery, 2020
Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer
Journal of Epidemiology & Community Health, 2007
Novel Biomarkers in Pancreatic Cancer
Pancreatic Cancer - Clinical Management, 2012
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy
International Journal of Cancer, 2013
K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
Gastroenterology, 1997
KRAS Mutant Status May Be Associated with Distant Recurrence in Early-stage Rectal Cancer
Anticancer Research, 2017
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Related papers
Pancreatic Cancer Cell DNA Content Correlates With Long-term Survival After Pancreatoduodenectomy
Annals of Surgery, 1991
Prognostic Value of Molecular Subtypes in Pancreatic Cancer
Pancreas, 2017
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Nature, 2012
Mutations in KRAS: are they a valid biomarker for pancreatic ductal adenocarcinomas diagnosis?
Translational Cancer Research, 2017
Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer
Molecular Cancer Therapeutics, 2021
Mutation Research/Reviews in Genetic Toxicology, 1992
JAMA, 2010
Genetic Effects and Modifiers of Radiotherapy and Chemotherapy on Survival in Pancreatic Cancer
Pancreas, 2011
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer
Nature Genetics, 2019
European Journal of Clinical Investigation, 2011
Cancer, 1993
Annals of Oncology, 2013
2011
Detection of K-ras mutations in lung carcinomas: Relationship to prognosis
Lung Cancer, 1996
Journal of the Pancreas, 2012
New Targets for Therapy in Pancreatic Cancer
cdn.intechopen.com
P0089 Pancreatic Cancer and Glucose Metabolism
European Journal of Internal Medicine, 2009
Overcoming diagnostic issues in precision treatment of pancreatic cancer
Expert review of precision medicine and drug development, 2018
Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer
JAMA surgery, 2018
Mutations of the Ki-ras oncogene in endometrial carcinoma
American Journal of Obstetrics and Gynecology, 1992
Diagnostic Value of K-ras Mutations in Serum of Pancreatic Cancer Patients
Annals of the New York Academy of Sciences, 2006
2014
Biotechnology & Biotechnological Equipment, 2016
Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors
Oncogene, 1999